O
OrbiMed Portfolio holdings
AUM
$3.98B
1-Year Est. Return
13.05%
1 Year Est. Return
+13.05%
AUM
$4.16B
AUM Growth
-$652M
(-14%)
Holding
122
Top Buys
| 1 | +$97.6M | |
| 2 | +$45.1M | |
| 3 | +$38.8M | |
| 4 |
UnitedHealth
UNH
|
+$36.8M |
| 5 |
Tarsus Pharmaceuticals
TARS
|
+$33.6M |
Top Sells
| 1 | +$117M | |
| 2 | +$82.6M | |
| 3 | +$77.9M | |
| 4 |
Intuitive Surgical
ISRG
|
+$54.8M |
| 5 |
Universal Health Services
UHS
|
+$48.3M |
Sector Composition
| 1 | Healthcare | 99.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SVA
1
DELISTED
Sinovac Biotech, Ltd
SVA
| $334M | 7.96% |
2,718,735
|
|
||
2
Edgewise Therapeutics
EWTX
$1.65B
| $330M | 7.88% |
15,021,721
|
|
||
3
Boston Scientific
BSX
$145B
| $284M | 6.77% |
2,813,200
-347,100
|
|
||
4
Eli Lilly
LLY
$741B
| $279M | 6.65% |
337,600
|
|
||
5
Enliven Therapeutics
ELVN
$1.29B
| $157M | 3.73% |
7,959,538
|
|
||
|
6
Intuitive Surgical
ISRG
$156B
| $144M | 3.44% |
291,000
-110,700
|
|
||
7
Stryker
SYK
$141B
| $134M | 3.19% |
359,200
+14,800
|
|
||
8
argenx
ARGX
$50.1B
| $122M | 2.92% |
206,700
+17,000
|
|
||
9
Edwards Lifesciences
EW
$43.1B
| $111M | 2.65% |
1,532,000
+386,698
|
|
||
|
10
UnitedHealth
UNH
$327B
| $105M | 2.51% |
201,200
+70,300
|
|
||
11
ARS Pharmaceuticals
SPRY
$1.05B
| $104M | 2.49% |
8,288,510
|
|
||
12
Neurocrine Biosciences
NBIX
$13.6B
| $103M | 2.46% |
934,640
-3,480
|
|
||
13
Pfizer
PFE
$139B
| $97.6M | 2.33% |
+3,850,200
|
|
||
14
Alnylam Pharmaceuticals
ALNY
$61.5B
| $93.5M | 2.23% |
346,100
-69,500
|
|
||
15
Integer Holdings
ITGR
$3.64B
| $78.2M | 1.86% |
662,500
+87,500
|
|
||
16
Vertex Pharmaceuticals
VRTX
$106B
| $77.5M | 1.85% |
159,900
+8,900
|
|
||
17
Natera
NTRA
$23.7B
| $77.4M | 1.84% |
547,000
+134,000
|
|
||
18
Ionis Pharmaceuticals
IONS
$11.4B
| $76.6M | 1.83% |
2,540,136
-277,211
|
|
||
19
Disc Medicine
IRON
$2.54B
| $70.2M | 1.67% |
1,415,020
-370,551
|
|
||
20
Thermo Fisher Scientific
TMO
$199B
| $64.2M | 1.53% |
129,000
+44,600
|
|
||
21
Tenet Healthcare
THC
$17.6B
| $62.5M | 1.49% |
465,000
-327,000
|
|
||
22
Cytokinetics
CYTK
$7.3B
| $60.7M | 1.45% |
1,509,205
-74,800
|
|
||
23
CG Oncology
CGON
$3.27B
| $60.5M | 1.44% |
2,471,994
+1,040,880
|
|
||
24
ArriVent BioPharma
AVBP
$811M
| $56M | 1.33% |
3,027,328
|
|
||
25
Avidity Biosciences
RNA
$7.36B
| $53.5M | 1.28% |
1,812,886
+700,000
|
|